API major, Lasa Supergenerics Ltd Received WHO Certificate of Good Manufacturing Practices from the Food and Drug Administration authorities for its manufacturing facility situated at Khed (Ratnagiri).
Commenting on the development, Dr Omkar Herlekar, Chairman- Lasa Supergenerics Limited, "WHO Good Manufacturing Practice certificate can be obtained by constant efforts towards improving the quality assurance as well as implementation of various systems on place, though we already have GMP for our other major units, we are also proud to receive this recognition for our Unit Located in Khed with the efforts of our Hardworking Team".
WHO GMP covers all aspects of production starting from the materials, premises and equipment to the training and personal hygiene of staff. Detailed, written procedures which are essential for each process that could affect the quality of the finished product. Systems to provide documented proof that correct procedures are consistently followed at each step in the manufacturing process - every time a product is made.
Besides saving costs with the help of consistent procedure in safe environment WHO GMP also helps in increasing the customers confidence for the company's products, enhances safety management controls, reduce operating costs by eliminating penalties which may be imposed due to noncompliance, attract exports attention etc.
WHO GMP guidelines are not prescriptive instructions on how to manufacture products. They are a series of general principles that must be observed during manufacturing.
Shares of Lasa Supergenerics Ltd was last trading in BSE at Rs.94.1 as compared to the previous close of Rs. 94.7. The total number of shares traded during the day was 61634 in over 786 trades.
The stock hit an intraday high of Rs. 97.35 and intraday low of 93.35. The net turnover during the day was Rs. 5877068.